Protocol for Project FACT: A randomised controlled trial on the effect of a walking program and vitamin B supplementation on the rate of cognitive decline and psychosocial wellbeing in older adults with mild cognitive impairment [ISRCTN19227688]

被引：14
作者：
Van Uffelen J.G.Z. [1 ,2 ,3 ]
Hopman-Rock M. [1 ,3 ]
Chin A Paw M.J.M. [1 ,2 ]
Van Mechelen W. [1 ,2 ]
机构：
[1] BodyatWork, Research Center Physical Activity, Work and Health, TNO-VU University Medical Center, Amsterdam
[2] Department of Public and Occupational Health, EMGO Institute, VU University Medical Center, Amsterdam
[3] Dep. of Physical Activity and Health, TNO Quality of Life, Leiden
来源：
BMC Geriatrics | / 5卷 / 1期
关键词：
Physical Activity; Homocysteine; Mild Cognitive Impairment; Alzheimer Disease; Homocysteine Level;
D O I：
10.1186/1471-2318-5-18
中图分类号：
学科分类号：
摘要：
Background: the prevalence of individuals with cognitive decline is increasing since the number of elderly adults is growing considerably. The literature provides promising results on the beneficial effect of exercise and vitamin supplementation on cognitive function both in cognitively healthy as well as in the demented elderly. Methods/Design: the design is a two-by-two factorial randomised controlled trial. The study population consists of independently living elderly, between 70 and 80 years old, with mild cognitive impairment (MCI). In the RCT the effect of two interventions, a walking program and vitamin supplementation, is examined. The walking program (WP) is a group-based program aimed at improving cardiovascular endurance; frequency two lessons a week; lesson duration one hour; program duration one year. Non-walking groups receive a placebo activity program (PAP) (i.e. low intensive non-aerobic group exercises, like stretching) with the same frequency, lesson and program duration. Vitamin supplementation consists of a single daily vitamin supplement containing 50 mg B6, 5 mg folic acid and 0,4 mg B12 for one year. Subjects not receiving vitamin supplements are daily taking an identically looking placebo pill, also for a year. Participants are randomised to four groups 1) WP and vitamin supplements; 2) WP and placebo supplements; 3) PAP and vitamin supplements; 4) PAP and placebo supplements. Primary outcome measures are measures of cognitive function. Secondary outcomes include psychosocial wellbeing, physical activity, cardiovascular endurance and blood vitamin levels. Discussion: no large intervention study has been conducted yet on the effect of physical activity and vitamin supplementation in a population-based sample of adults with MCI. The objective of the present article is to describe the design of a randomised controlled trial examining the effect of a walking program and vitamin B supplementation on the rate of cognitive decline in older adults with MCI. © 2005 van Uffelen et al; licensee BioMed Central Ltd.
引用
收藏
页数：9
相关论文
共 69 条
[1]  
Petersen R.C., Doody R., Kurz A., Mohs R.C., Morris J.C., Rabins P.V., Ritchie K., Rossor M., Thal L., Winblad B., Current concepts in mild cognitive impairment, Arch Neurol, 58, pp. 1985-1992, (2001)
[2]  
Ganguli M., Dodge H.H., Shen C.Y., DeKosky S.T., Mild cognitive impairment, amnestic type - An epidemiologic study, Neurology, 63, pp. 115-121, (2004)
[3]  
Jungwirth S., Weissgram S., Zehetmayer S., Tragl K.H., Fischer P., VITA: Subtypes of mild cognitive impairment in a communitybased cohort at the age of 75 years, International Journal of Geriatric Psychiatry, 20, pp. 452-458, (2005)
[4]  
Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E., Mild cognitive impairment: Clinical characterization and outcome, Arch Neurol, 56, pp. 303-308, (1999)
[5]  
Ritchie K., Touchon J., Mild cognitive impairment: Conceptual basis and current nosological status, Lancet, 355, pp. 225-228, (2000)
[6]  
Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T., Practice parameter: Early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 56, pp. 1133-1142, (2001)
[7]  
Chertkow H., Mild cognitive impairment, Curr Opin Neurol, 15, pp. 401-407, (2002)
[8]  
Yesavage J.A., O'Hara R., Kraemer H., Noda A., Taylor J.L., Ferris S., Gely-Nargeot M.C., Rosen A., Friedman L., Sheikh J., Derouesne C., Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment, J Psychiatr Res, 36, pp. 281-286, (2002)
[9]  
Laurin D., Verreault R., Lindsay J., MacPherson K., Rockwood K., Physical activity and risk of cognitive impairment and dementia in elderly persons, Arch Neurol, 58, pp. 498-504, (2001)
[10]  
Schuit A.J., Feskens E.J., Launer L.J., Kromhout D., Physical activity and cognitive decline, the role of the apolipoprotein e4 allele, Med Sci Sports Exerc, 33, pp. 772-777, (2001)
1234567